AIRT Q1 2026 Earnings Profitability Surprise Drives Share Gains Despite Sparse Data STLA Q1 2026 Earnings EPS Misses Estimates as Company Navigates Transition Challenges SPME Q1 2026 Earnings EPS Misses Estimates amid Portfolio Headwinds Atossa Therapeutics Q1 2026 Earnings Narrowed Loss Beats Estimates as Clinical Pipeline Advances Nexalin Technology Inc NXL Q1 2026 Earnings EPS Misses Estimates as PreRevenue Company Intensifies RD Spend Indaptus Therapeutics Q4 2025 Earnings EPS Misses Estimates on Minimal Revenue Stock Surges